Friday, October 2, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 26, 2026

AITX's RAD Unveils RADSight 2.0 as the Next Evolution of Its Video Management Platform

View original at finance.yahoo.com
AITX's RAD Unveils RADSight 2.0 as the Next Evolution of Its Video Management Platform Designed for NVIDIA Jetson Processors, Advanced Edge Based Analytics, Autonomous Engagement, and the Demands of Modern Security Operations Detroit, Michigan--(Newsfile Corp…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • RAD expects to continue to attract new business as it converts existing sales opportunities into deployed clients generating recurring revenue stream

    80% confidence

  • RADSight 2.0 architecture is expected to reduce overall power consumption by more than half compared to prior configurations

    80% confidence

  • Each Fortune 500 client has the potential of making numerous reorders over time

    80% confidence

  • The security and guarding services industry is nearly $50 billion (US)

    80% confidence

  • RAD solutions provide cost savings to businesses of between 35%-80% when compared to manned security guarding and monitoring

    80% confidence

  • This evolution strengthens AITX's ability to deliver intelligent, reliable security solutions as market demand for autonomous and software-driven protection continues to grow

    80% confidence

  • RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities

    80% confidence

  • RADSight 2.0 rollout is expected to begin in February across Gen 4 device lineup

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI-Driven Drug Development Meets Biotech Deal-Making and Regulatory Catalysts
AI-designed therapeutics (Insilico's rentosertib showing biological-age reductions) are moving into the clinical mainstream. Large-cap biotech is simultaneously reallocating capital through M&A (Lilly–Merida, $2.9B) and government funding (BARDA–Basilea), while trial failures (ziltivekimab, a 9.4% Novo Nordisk share drop) and upcoming FDA catalysts (the ivonescimab PDUFA on 2026-11-14) drive volatility. The wider AI regulatory and legal climate (Tesla Cybercab probe, xAI's Minnesota loss, OpenAI suits) is tightening, though QAIAx's micro-cap trial claims are speculative and weakly connected.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,327 source documents archived
Query this data → isubstrate.com